Comparison of tacrolimus concentrations measured by the IMx Tacrolimus II vs the PRO-TRAC II FK506 ELISA assays

Clinical Chemistry

Volumn 45, Issue 10, 1999, Pages 1868-1870

  Jevans, Anthony W ^b  

^a Tim)   (United States)

^b JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; DRUG DETERMINATION; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; ORGAN TRANSPLANTATION;

EID: 0032850663     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.10.1868     Document Type: Article

References (11)

1. 1. MacFarlane G, Scheller D, Ersfeld D, Jensen T, Jevans A, Wong PY, Kobayashi M. A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) from tacrolimus (FK506) using proteolytic extraction in place of organic solvents. Ther Drug Monit 1996;18:698-705.
2. 2. Tredger JM, Gilkes CD, Gonde CE. Therapeutic monitoring of tacrolimus (FK506) with first- and second-generation microparticle enzyme immunoassays: performance and results in four patient populations. Ther Drug Monit 1998;20:266-75.
3. 3. Wallenmacq PE, Leal T, Besse T, Squifflet J P, Reding R, Otte J B, et al. lMx Tacrolimus II vs Tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem 1997;43:1989-91.
4. 4. Cao Z, Linder M, Brown G, Valdes R Jr. Evaluation of the new Tacrolimus II microparticle enzyme immunoassay [Abstract]. Ther Drug Monit 1997;19:564.
5. 5. Murthy JN, Soldin SJ. Performance characteristics of the Abbott Tacrolimus-II lMx assay [Abstract]. Ther Drug Monit 1997;19:559.
6. 6. Strike PW. Medsnap. A statistical toolkit for health professionals, Ver. 2 [Computer program]. Oxford, UK: Butterworth-Heinemann, 1996.
7. 7. Bland JM, Altman DG. Comparing methods of measurement: Why plotting difference against standard method is misleading. Lancet 1995;346:1085-7.
8. 8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
9. 9. Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Morris RL, et al. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two Immunoassays in patients with liver and renal transplants. Ther Drug Monit 1997;19:694-700.
10. 10. Cogill JL, Taylor PJ, Westley IS, Morris RG, Lynch SV, Hohnson AG. Evaluation of the Tacrollmus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998;44:1942-6.
11. 11. MacFarlane G, Scheller D, Ersfeld D, Fox B, Obritsch J, Roesler J. Analytical characterization of the ProTrac II ELISA for the determination of tacrolimus in whole blood [Abstract]. Ther Drug Monit 1997;19:559.